Frontlight ResearchEarly access
Liver and biliary tract cancer trials in United States
302 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationProspective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
- Where
- Bethesda
- Age
- 18 years and over
- People
- 1,200
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05600933 - Phase 2Taking peopleThe Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
- Where
- Fairfax, Falls Church
- Age
- 18 years and over
- People
- 19
- Run by
- Inova Health Care Services
See details and how to joinNCT06789757 - Phase 1/2Taking peopleAVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Where
- Atlanta, Boston, Dallas, Denver, Fairfax, Gilbert, Houston, Los Angeles, New Haven, New York, Orlando, Philadelphia, San Antonio, Sarasota, Seattle, Tampa, Washington D.C., West Valley City
- Age
- 18 years to 75 years
- People
- 480 worldwide
- Run by
- Avenzo Therapeutics, Inc.
See details and how to joinNCT07038343 - Phase 1Taking peopleA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Huntersville, Irving
- Age
- 18 years and over
- People
- 130
- Run by
- AbbVie
See details and how to joinNCT07807956 · EU 2026-526097-17-00 - No phaseNot yet taking people in United StatesEstimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image Registration
- Where
- Houston
- Age
- 18 years and over
- People
- 200
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07877220 - Phase 1/2Not yet taking people in United StatesStudy of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma
- Where
- Dallas
- Age
- 18 years and over
- People
- 36
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT07878689 - Phase 2Taking peopleA Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 20
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT05901519 - Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Age
- 18 years and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - Phase 1/2Taking peopleA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Denver, Detroit, New York, Orlando
- Age
- 18 years and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842 · EU 2025-522613-26-00 - Phase 1Taking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Aurora, Charleston, Chicago, Cleveland, Denver, Duarte, Durham, Fairfax, Grand Rapids, Greenville, Houston, Nashville, New York, Providence, San Antonio, San Francisco, Sarasota, St Louis
- Age
- 18 years and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - No phaseTaking peopleValue of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
- Where
- Charlestown
- Age
- 18 years to 99 years
- People
- 45
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06265272 - Phase 1/2Taking peopleFirst in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
- Where
- Baltimore, Boston, Hackensack, Houston, La Jolla, Los Angeles, St Louis
- Age
- 18 years and over
- People
- 304 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06795022 · EU 2024-516698-56-00 - Phase 1Taking peopleSafety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- Where
- Baltimore, Boston, Detroit, Los Angeles, Nashville, New York, San Francisco, Stanford, Westwood
- Age
- 18 years and over
- People
- 125 worldwide
- Run by
- Tyra Biosciences, Inc
See details and how to joinNCT06915753 - Phase 1Taking peopleTCR1188-ABC Cells in KRAS-mutated Cancers
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- University of Pennsylvania
See details and how to joinNCT07594067 - No phaseTaking peopleA Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
- Where
- Basking Ridge, Commack, Harrison, New York
- Age
- 18 years and over
- People
- 80
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT03432806 - Phase 1Taking peopleOpen Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Where
- Augusta, Birmingham, Boston, Chicago, Detroit, Duarte, East Brunswick, Fairfax, Fort Worth, Houston, Lake Success, Los Angeles, Miami, Mineola, Nashville, New York, Orlando, Portland, San Antonio, San Diego, St Louis, Zion
- Age
- 18 years and over
- People
- 280
- Run by
- SystImmune Inc.
See details and how to joinNCT06293898 - Phase 3Taking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Albuquerque, Atlanta, Austin, Boston, Chicago, Cleveland, Coeur d'Alene, Columbus, Dallas, Detroit, Fairfax, Fort Myers, Fort Worth, Fullerton, Grand Rapids, Greenville, Houston, Jacksonville, Kansas City, La Jolla, Los Alamitos, Los Angeles, Nashville, New York, Niles, Pearland, Pittsburgh, Rochester, San Antonio, San Francisco, Scottsdale, St Louis, St. Petersburg, Tampa, Towson, Tucson, Walnut Creek, Washington D.C., West Palm Beach, White Plains, Worcester
- Age
- 18 years to 99 years
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - Phase 3Taking peoplePhase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Where
- Amarillo, Arlington, Atlanta, Austin, Chicago, Cleveland, Dallas, Denver, Detroit, Grand Rapids, Honolulu, Houston, Indianapolis, Jacksonville, Los Angeles, Milwaukee, Newark, New Brunswick, New Haven, New York, Oklahoma City, Orlando, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Rochester, Salem, San Antonio, Seattle, Shreveport, St Louis, Tucson, Tyler
- Age
- 18 years and over
- People
- 1,220 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00 - Phase 4Taking peopleMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- Where
- Portland
- Age
- 18 years and over
- People
- 160
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07405086 - Phase 2Not yet taking people in United StatesUtilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin
- Where
- San Francisco
- Age
- 18 years and over
- People
- 50
- Run by
- University of California, San Francisco
See details and how to joinNCT07682454 - Phase 1/2Taking peopleA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Where
- Fairfax, Huntersville, New York, San Antonio
- Age
- 18 years and over
- People
- 499
- Run by
- Arvinas Inc.
See details and how to joinNCT07749586 · EU 2026-525614-57-00 - No phaseTaking peopleTumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
- Where
- Columbia
- Age
- 18 years and over
- People
- 320
- Run by
- University of Missouri-Columbia
See details and how to joinNCT03551951 - No phaseTaking peoplePsychoeducational Intervention for Patients With Hepatocellular Carcinoma
- Where
- Boston
- Age
- 18 years and over
- People
- 50
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06541990 - Phase 4Enrolling by invitationAtezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
- Where
- Houston
- Age
- 18 years and over
- People
- 24 worldwide
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT05185505 - Phase 1/2Taking peopleSymbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
- Where
- Cary, City of Saint Peters, Cleveland, Coon Rapids, Creve Coeur, Durham, Florissant, Irvine, Kansas City, Land O' Lakes, Los Angeles, Minneapolis, Orange, Pasadena, Pittsburgh, Raleigh, Reno, Ruskin, Saint Paul, Seattle, Shiloh, St Louis, Tampa, Wesley Chapel
- Age
- 18 years and over
- People
- 138 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227012 · EU 2025-523525-17-00